Related Experiment Video
Updated: Oct 24, 2025
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.6K
[Tumor vaccination-strategies and time points]
Yacine Maringer1,2,3, Juliane S Walz4,5,6,7
1Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Deutschland.
Der Internist
|August 16, 2021
Summary
Tumor vaccines direct the immune system against cancer cells. Effective vaccination requires specific tumor antigens and diverse strategies are being evaluated in clinical trials for long-term protection.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Cancer immunotherapies, including tumor vaccines, are increasingly vital in cancer treatment.
- Tumor vaccines harness the immune system to target cancer cells specifically.
Purpose of the Study:
- To discuss various tumor vaccination strategies, their development status, optimal timing, and combination therapies.
- To provide an overview of current research and clinical applications of cancer vaccines.
Main Methods:
- Summarized scientific publications on tumor vaccination strategies.
- Reviewed ongoing studies listed on clinicaltrials.gov.
Main Results:
- Effective tumor vaccination depends on selecting suitable tumor antigens (neoepitopes or TAAs) presented by HLA molecules.
- Antigens must be tumor-specific and elicit a potent anti-tumor immune response, activating cytotoxic and T-helper cells.
Conclusions:
- Various vaccine application strategies exist, including peptide, DNA, RNA, dendritic cell, and whole tumor cell vaccines, often combined with adjuvants.
- Numerous vaccination approaches and combination protocols are under clinical evaluation to develop specific, low-side-effect immunotherapies for long-term cancer protection.
Related Concept Videos
01:27Tumor Immunotherapy
773
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
773
01:30Cancer Vaccines
576
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
576